Home · FSC 6505 Drugs And Biologicals · NSN 6505-01-374-5874
NSN 6505-01-374-5874 — Sumatriptan Succinate Injection
NIIN 01-374-5874 · unit of issue PG · AAC L (not stocked, local purchase) · source of supply SMS
NSN 6505-01-374-5874 is the national stock number for a sumatriptan succinate injection in federal supply class 6505 (Drugs And Biologicals). It cross-references to 3 manufacturer part numbers from 5 CAGE codes, including Veterans Health, Amerisourcebergen Drug Corp, Glaxo Wellcome Inc; the primary is IMITREX. The unit of issue is PG and the FLIS list price is $964.85.
The U.S. government has bought this item 19 times on record, 2 of them in the last 24 months, most recently on July 21, 2026 at $49.84 each from Dms Pharmaceutical Group Inc. The median unit price paid over 36 months is $355.17. 1 solicitation is open right now, the soonest due September 30, 2026 for 5 PG. No seller has confirmed stock of it here in the last 60 days; watching the number is free and the first listing triggers an alert.
3
part numbers from 5 CAGEs
1
open solicitation, all agencies
2
government buys in 24 months · median $355.17
0
sellers with confirmed stock
Cross-references
Part numbers filed against this stock number, with the manufacturer (CAGE) and the FLIS reference codes.
| Part number | CAGE | Manufacturer | Reference | Variation |
|---|---|---|---|---|
| NDC00173-0449-02 | 4LQT5 | Veterans Health | 3 · Design control (vendor) | 1 · Not fully interchangeable |
| NDC00173-0449-02 | 1XUY5 | Amerisourcebergen Drug Corp | 3 · Design control (vendor) | 1 · Not fully interchangeable |
| NDC00173-0449-02 | 34006 | Glaxo Wellcome Inc | 3 · Design control (vendor) | 2 · Fully interchangeable |
| IMITREX | 34006 | Glaxo Wellcome Inc | 5 · Secondary reference | 1 · Not fully interchangeable |
| IMITREX INJECTION | 34006 | Glaxo Wellcome Inc | 5 · Secondary reference | 1 · Not fully interchangeable |
| NDC00173-0449-02 | 1GAU9 | Cardinal Health 100, Inc. | 5 · Secondary reference | 9 · Reference only |
| NDC00173-0449-02 | 0A423 | Cardinal Health 100, Inc Dba Bindley Western Tennessee Div | 5 · Secondary reference | 9 · Reference only |
Government demand
Open DLA RFQs (DIBBS)
- SPE2DP26T5215 · 5 PG · due Sep 30, 2026 · N · AMSC Z · DIBBS
What the government paid
| Date | Vendor | Qty | Unit cost | Amount | Buyer | Reference |
|---|---|---|---|---|---|---|
| Jul 21, 2026 | Dms Pharmaceutical Group Inc 1UNB0 | 1 | $49.84 | Dla | SPE2DP26F7886 | |
| Dec 29, 2025 | Mr Unlimited, LLC 3W8H0 | 2 | $660.50 | Dla | SPE2DP26V0275 | |
| Jul 14, 2022 | Cardinal Health, Inc. 00E55 | 2 | $660.51 | Dla | SPE2D922F3616 | |
| Apr 25, 2022 | Cardinal Health, Inc. 00E55 | 2 | $660.51 | Dla | SPE2D922F2445 | |
| May 4, 2021 | Dms Pharmaceutical Group Inc 1UNB0 | 1 | $672.47 | Dla | SPE2DP21F3757 | |
| Oct 12, 2019 | Dms Pharmaceutical Group Inc 1UNB0 | 1 | $644.61 | Dla | SPE2DP20F0208 | |
| Mar 25, 2018 | Dms Pharmaceutical Group Inc 1UNB0 | 2 | $499.16 | Dla | SPE2DP18F2408 | |
| Mar 2, 2018 | Dms Pharmaceutical Group Inc 1UNB0 | 1 | $499.16 | Dla | SPE2DP18F2081 | |
| Nov 3, 2017 | Dms Pharmaceutical Group Inc 1UNB0 | 1 | $488.27 | Dla | SPE2DP18F0567 | |
| Jul 24, 2017 | Dms Pharmaceutical Group Inc 1UNB0 | 1 | $496.21 | Dla | SPE2DX15D93835965 | |
| Feb 15, 2017 | Dms Pharmaceutical Group Inc 1UNB0 | 1 | $496.21 | Dla | SPE2DX15D93834687 | |
| Jul 22, 2016 | Cardinal Health, Inc. 00E55 | 2 | $281.46 | Dla | SPE2DX15D00227707 | |
| May 9, 2016 | Cardinal Health, Inc. 00E55 | 2 | $281.46 | Dla | SPE2DX15D00226918 | |
| Feb 15, 2016 | Cardinal Health, Inc. 00E55 | 1 | $281.46 | Dla | SPE2DX15D00225373 | |
| Dec 2, 2015 | Cardinal Health, Inc. 00E55 | 1 | $328.27 | Dla | SPE2DX15D00223818 | |
| Nov 13, 2015 | Cardinal Health, Inc. 00E55 | 1 | $328.27 | Dla | SPE2DX15D00223590 | |
| Sep 29, 2015 | Cardinal Health, Inc. 00E55 | 1 | $328.27 | Dla | SPE2DX15D00222348 | |
| Aug 24, 2015 | Cardinal Health, Inc. 00E55 | 2 | $328.27 | Dla | SPE2DX15D00221059 | |
| Jul 10, 2015 | Cardinal Health, Inc. 00E55 | 2 | $328.27 | Dla | SPE2DX15D00220291 |
Sources: DLA DIBBS procurement history (unit cost), DLA award history, FPDS (all agencies), SAM.gov notices. 19 buys on record in total.
Sellers with confirmed stock
No seller has confirmed stock on this NSN in the last 60 days. Watch it and we will email you when one does, or request a quote on IMITREX.
Listings appear here only while the seller has confirmed them within 60 days. Sellers: list this part free.
DLA management data
- FLIS unit price
- $964.85
- Unit of issue
- PG
- Acquisition advice
- L — Not stocked, local purchase
- Source of supply
- SMS
- Shelf life code
- M
- Effective
- Jun 4, 2026
Item characteristics
- Active Medicament Medicinal Strength
- MILLIGRAMS SUMATRIPTAN SUCCINATE PER 0.5 MILLILITERS 6.000
- Primary Container Type
- VIAL, SINGLE DOSE
- Primary Container Content Quantity
- MILLILITERS 2.000
- Total Primary Container Quantity
- 5
- Part Name Assigned By Controlling Agency
- SUMATRIPTAN SUCCINATE INJECTION 6MG/0.5ML 2ML VIAL 5S
- Therapeutic Equivalent
- TO IMITREX BY GLAXO
About this page
An NSN is 13 digits: the 4-digit Federal Supply Class and the 9-digit NIIN. Cross-references come from the federal logistics record; demand from DLA DIBBS, SAM.gov and FPDS; ADs from the Federal Register. Refreshed nightly. Market Pulse shows the whole market.
Get the daily Market Pulse
New DLA RFQs, SAM.gov notices, yesterday's awards and FAA directives, weekday mornings. Free, one click to leave.